Raju Mohan - 05 Apr 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
05 Apr 2023
Net transactions value
-$612,401
Form type
4
Filing time
07 Apr 2023, 15:47:21 UTC
Previous filing
18 Jan 2023
Next filing
12 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $300,956 -10,165 -0.63% $29.61 1,592,961 05 Apr 2023 Direct F1, F2
transaction VTYX Common Stock Sale $93,455 -3,065 -0.19% $30.49 1,589,896 05 Apr 2023 Direct F1, F3
transaction VTYX Common Stock Sale $217,991 -7,515 -0.47% $29.01 1,582,381 06 Apr 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
F2 Represents the weighted average share price of an aggregate total of 10,165 shares sold in the price range of $29.00 to $29.9994. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 3,065 shares sold in the price range of $30.0008 to $30.835. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average share price of an aggregate total of 7,515 shares sold in the price range of $29.00 to $29.085. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.